LLY and PFE beat handily. VRTX blew a fart and wet their pants. Ho hum report. No step back, no step forward. So they are selling it off. Everyone knows a good trial result in Hep C or CF is needed. Until then, we go nowhere. Dead money at best. Let's hope 44 holds.